PTCT Maintained by Cantor Fitzgerald -- Price Target Raised to $137

gurufocus.com · 2026-09-22

PTC Therapeutics Analyst Rating Update On September 22, 2026, PTC Therapeutics (PTCT) received a maintained rating from Cantor Fitzgerald, with analyst Krist

Read the full story at gurufocus.com →